Alburx Related Published Studies
Well-designed clinical trials related to Alburx (Albumin Human)
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. [2011.07]
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT). [2011.06]
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. [2011.06]
Co-administration of albumin-furosemide in patients with the nephrotic syndrome. [2011.05]
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. [2011.05]
Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. [2011.05]
Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy. [2011.05]
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. [2011.04]
Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker. [2011.04]
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. [2011.03.14]
The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. [2011.02]
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial. [2011.02]
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. [2011.02]
The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. [2011.01]
Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus. [2011]
Metabolic effects of albumin therapy in acute lung injury measured by proton
nuclear magnetic resonance spectroscopy of plasma: a pilot study. [2011]
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. [2011]
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation
in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients
with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. [2011]
Office and ambulatory pulse pressure--association with clinical characteristics
and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes
(ROADMAP study). [2011]
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. [2010.08]
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria. [2010.06]
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. [2010.05.27]
99m Tc-albumin nanocolloid joint scintigraphy in rheumatoid arthritis patients who are in clinical remission - is remission real ? [2010.05]
Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. [2010.05]
Lipoprotein profile, plasma ischemia modified albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study. [2010.04.19]
[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease] [2010.03.16]
Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy. [2010.02]
Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study. [2010]
Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes. [2010]
Human albumin for intradialytic hypotension in haemodialysis patients. [2010]
[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid
mobilisation in Alzheimer's disease]. [Article in Spanish] [2010]
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics
and clinical response in patients with ulcerative colitis. [2010]
Effects of saline or albumin resuscitation on standard coagulation tests. [2009.12]
Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. [2009.12]
Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. [2009.11]
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. [2009.09]
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. [2009.07.07]
Albumin versus normal saline for dehydrated term infants with metabolic acidosis due to acute diarrhea. [2009.06]
Effect of Albumin Administration Prior to Exchange Transfusion in Term Neonates with Hyperbilirubinemia A Randomized Controlled Trial. [2009.05.20]
Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. [2009.05]
A breakfast with alpha-lactalbumin, gelatin, or gelatin + TRP lowers energy intake at lunch compared with a breakfast with casein, soy, whey, or whey-GMP. [2009.04]
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. [2009.04]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. [2009.04]
Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. [2009.04]
Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. [2009.03]
Avosentan reduces albumin excretion in diabetics with macroalbuminuria. [2009.03]
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. [2009.02]
Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. [2009.02]
High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. [2009.02]
The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study. [2009.01]
Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. [2009]
Well-designed clinical trials possibly related to Alburx (Albumin Human)
Hepatic safety of injectable extended-release naltrexone in patients with chronic
hepatitis C and HIV infection. [2012]
Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation
in Asian patients with atherosclerosis. [2012]
STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized
placebo-controlled trial evaluating perioperative atorvastatin therapy in
noncardiac surgery. [2012]
A randomized, double blind, placebo and active comparator controlled pilot study
of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical
origin. [2012]
Efficacy of a high-dose in addition to daily low-dose vitamin A in children
suffering from severe acute malnutrition with other illnesses. [2012]
The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. [2012]
What is the best method of proteinuria measurement in clinical trials of
endothelin receptor antagonists? [2012]
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan,
in patients with diabetes and chronic kidney disease (CKD). [2012]
Adalimumab induces and maintains mucosal healing in patients with Crohn's
disease: data from the EXTEND trial. [2012]
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy
in chronic obstructive pulmonary disease. [2012]
Effects of red ginseng supplementation on menopausal symptoms and cardiovascular
risk factors in postmenopausal women: a double-blind randomized controlled trial. [2012]
Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing
surgery on cardiopulmonary bypass: a pilot randomized, double-blind,
placebo-controlled trial. [2012]
Evaluation of abatacept administered subcutaneously in adults with active
rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity,
efficacy and safety (phase Iiib ALLOW study). [2012]
Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress,
and serum lipid profile levels in patients with end-stage renal disease on
hemodialysis. [2012]
High-dose curcuminoids are efficacious in the reduction in symptoms and signs of
oral lichen planus. [2012]
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's
disease: results from the CHARM trial. [2012]
The effects of isoflavones combined with soy protein on lipid profiles,
C-reactive protein and cardiovascular risk among postmenopausal Chinese women. [2012]
OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. [2011.12]
Intake of milk with added micronutrients increases the effectiveness of an energy-restricted diet to reduce body weight: a randomized controlled clinical trial in Mexican women. [2011.10]
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. [2011.10]
Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study. [2011.10]
Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. [2011.09.06]
The usefulness of a preoperative compact imager, a hand-held gamma-camera for breast cancer sentinel node biopsy: final results of a prospective double-blind, clinical study. [2011.09]
Coronary circulatory function in patients with the metabolic syndrome. [2011.09]
Strawberry anthocyanin and its association with postprandial inflammation and insulin. [2011.09]
Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor alpha are attenuated by prandial + basal insulin in patients with Type 2 diabetes. [2011.09]
Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. [2011.09]
The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. [2011.09]
Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction. [2011.09]
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. [2011.08.09]
Prophylactic intra-aortic balloon pump reduces C-reactive protein levels and early mortality in high-risk patients undergoing percutaneous coronary intervention. [2011.08]
A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department. [2011.08]
Inflammation related to synovectomy during total knee replacement in patients with primary osteoarthritis: a prospective, randomised study. [2011.08]
The effects of urinary trypsin inhibitor on liver function and inflammatory factors in patients undergoing hepatectomy: a prospective, randomized, controlled clinical study. [2011.08]
Dairy attentuates oxidative and inflammatory stress in metabolic syndrome. [2011.08]
A high antioxidant spice blend attenuates postprandial insulin and triglyceride responses and increases some plasma measures of antioxidant activity in healthy, overweight men. [2011.08]
Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. [2011.08]
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial. [2011.08]
Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-alpha (EORTC 18952) and prognostic value on treatment outcome. [2011.08]
Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. [2011.08]
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial. [2011.07.27]
The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. [2011.07.01]
Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. [2011.07]
Lung cancer chemoprevention with celecoxib in former smokers. [2011.07]
Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. [2011.07]
Inflammatory and tumor stimulating responses after laparoscopic sigmoidectomy. [2011.07]
Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot). [2011.07]
Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. [2011.07]
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study. [2011.07]
Rosuvastatin in diabetic hemodialysis patients. [2011.07]
|
